We are live on ! Find out more
FFVM

Founders Fund V Management Portfolio holdings

AUM $2.16M
1-Year Est. Return 77.37%
This Fund
S&P 500
This Quarter Est. Return
+1,479.4%
1 Year Est. Return
+77.37%
3 Year Est. Return
+859.57%
5 Year Est. Return
-74.2%
10 Year Est. Return
AUM
$1.68M
AUM Growth
+$1.11M
Cap. Flow
-$50.7K
Cap. Flow %
-3.01%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NTBL
Notable Labs, Ltd. Ordinary Shares
NTBL
+$50.7K

Sector Composition

Rank Sector Weight
1 Technology 80.31%
2 Healthcare 19.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGTI icon
1
Rigetti Computing
RGTI
$4.94B
$1.35M 80.31%
88,621
CYTH
2
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$284K 16.84%
480,708
UBX
3
DELISTED
Unity Biotechnology
UBX
$48K 2.85%
49,172
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
-117,924
Closed -$50.7K

Similar funds

Founders Fund V Management's Q4 2024 Portfolio in Review

As of Q4 2024, Founders Fund V Management held 4 positions worth $1.68M, up 195% from $572K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund V Management withdrew a net $50.7K in Q4 2024, closing 1 position. Its most notable exit was Notable Labs, Ltd. Ordinary Shares, an estimated $50.7K position sold in full.

By sector, the portfolio is most concentrated in Technology at 80% of assets, up from 12% a quarter earlier, followed by Healthcare.

  • Founders Fund V Management fully exited Notable Labs, Ltd. Ordinary Shares in Q4 2024, selling an estimated $50.7K.
  • Founders Fund V Management's ten largest holdings make up 100% of its $1.68M portfolio in Q4 2024.
  • Founders Fund V Management opened 0 new positions and closed 1 in Q4 2024.
  • Founders Fund V Management's portfolio value rose 195% quarter-over-quarter to $1.68M.

Based on Founders Fund V Management's 13F filing for Q4 2024, filed 14 Feb 2025.